Related Experiment Video
Updated: Jun 9, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Management of Jehovah's Witness patients with haematological problems
1Department of Haematology, University College London Hospitals NHS Trust, Grafton Way, London, UK.
Abstract:
The management of practising Jehovah's Witnesses who have haematological problems presents many different challenges both at the level of treatment strategy and ethics. This article focuses on the beliefs of Jehovah's Witnesses and addresses treatment modalities available for and acceptable to these individuals. Recent advances in the development of novel therapeutic agents have aided the management of Jehovah's Witnesses. Finally, the background to the ethical dilemmas raised by these issues is discussed.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Venous Thrombosis IV: Nursing Management
Hemodialysis III: Nursing Management